MTA1 and hepatocellular carcinoma: Moreover, MTA1 overexpression in patients with HBV-HCC was significantly associated with several clinical factors, including younger age, female gender, higher serum alpha-fetoprotein level, and Child-Turcotte-Pugh class A [160].